Ignite Creation Date:
2025-12-24 @ 3:33 PM
Ignite Modification Date:
2026-03-18 @ 12:41 AM
Study NCT ID:
NCT00114192
Status:
COMPLETED
Last Update Posted:
2010-02-01
First Post:
2005-06-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor:
University of Virginia
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
11212
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |